Literature DB >> 10725705

The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells.

W A Chow1, J J Fang, J K Yee.   

Abstract

TCR engagement leads to the transcriptional activation of cytokine genes and activation-induced cell death. Activated T cells undergo apoptosis upon expression and ligation of Fas ligand (FasL) to Fas/APO-1 (CD95) receptor. FasL expression is under the transcriptional regulation of multiple factors. The present study demonstrates that TCR-inducible FasL expression is also under the direct influence of the IFN regulatory factor (IRF) transcription factor family. Deletion and mutagenesis of a putative IRF-1 binding site in the FasL promoter results in deficient expression of FasL. EMSAs demonstrate specific FasL promoter binding by IRF-1 and IRF-2. Forced expression of either IRF-1 or IRF-2 leads to FasL promoter activation in T cells and FasL expression in heterologous cells. Finally, suppression of IRF-1 expression in T cells results in deficient TCR-induced FasL expression. These results confirm that the IRF family participates in the regulation of FasL gene expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725705     DOI: 10.4049/jimmunol.164.7.3512

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis.

Authors:  Yanxia Ning; Rebecca B Riggins; Jennifer E Mulla; Haniee Chung; Alan Zwart; Robert Clarke
Journal:  Mol Cancer Ther       Date:  2010-05       Impact factor: 6.261

2.  Replacement of the C-terminal tetrapeptide (314 PAPV 317 to 314 SSSM 317) in interferon regulatory factor-2 alters its N-terminal DNA-binding activity.

Authors:  Krishna Prakash; Pramod C Rath
Journal:  J Biosci       Date:  2010-12       Impact factor: 1.826

3.  FasL expression in activated T lymphocytes involves HuR-mediated stabilization.

Authors:  Gillian L Drury; Sergio Di Marco; Virginie Dormoy-Raclet; Julie Desbarats; Imed-Eddine Gallouzi
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

4.  Induction of rapid T cell death and phagocytic activity by Fas-deficient lpr macrophages.

Authors:  Ritsuko Oura; Rieko Arakaki; Akiko Yamada; Yasusei Kudo; Eiji Tanaka; Yoshio Hayashi; Naozumi Ishimaru
Journal:  J Immunol       Date:  2012-12-19       Impact factor: 5.422

5.  Glucocorticoid-induced leucine zipper (GILZ) promotes the nuclear exclusion of FOXO3 in a Crm1-dependent manner.

Authors:  Perle Latré de Laté; Aurélie Pépin; Hind Assaf-Vandecasteele; Christophe Espinasse; Valérie Nicolas; Marie-Liesse Asselin-Labat; Jacques Bertoglio; Marc Pallardy; Armelle Biola-Vidamment
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

6.  Antiproliferative effect of 13-cis-retinoic acid is associated with granulocyte differentiation and decrease in cyclin B1 and Bcl-2 protein levels in G0/G1 arrested HL-60 cells.

Authors:  Ana Vuletic; Gordana Konjevic; Desanka Milanovic; Sabera Ruzdijic; Vladimir Jurisic
Journal:  Pathol Oncol Res       Date:  2010-01-19       Impact factor: 3.201

7.  Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Authors:  Robert Clarke; Ayesha N Shajahan; Rebecca B Riggins; Younsook Cho; Anatasha Crawford; Jianhua Xuan; Yue Wang; Alan Zwart; Ruchi Nehra; Minetta C Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03       Impact factor: 4.292

8.  IL28B genotype and the expression of ISGs in normal liver.

Authors:  Zoe Raglow; Carly Thoma-Perry; Richard Gilroy; Yu-Jui Y Wan
Journal:  Liver Int       Date:  2013-03-24       Impact factor: 5.828

9.  Bim nuclear translocation and inactivation by viral interferon regulatory factor.

Authors:  Young Bong Choi; John Nicholas
Journal:  PLoS Pathog       Date:  2010-08-05       Impact factor: 6.823

10.  IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells.

Authors:  J Gao; M Senthil; B Ren; J Yan; Q Xing; J Yu; L Zhang; J H Yim
Journal:  Cell Death Differ       Date:  2009-10-23       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.